Bruker | BRKR - Sales Revenues


Bruker reported $977.2M in Sales Revenues for its fiscal quarter ending in December of 2025.





Sales Change Date
ABB USD 8.73B 322M Mar/2026
Agilent USD 1.8B 63M Dec/2025
Ametek USD 2B 110M Dec/2025
Bio Techne USD 295.9M 9.34M Dec/2025
Bio-Rad Laboratories USD 693.2M 40.2M Dec/2025
Bruker USD 977.2M 116.7M Dec/2025
Charles River Laboratories USD 994.2M 5.8M Dec/2025
Danaher USD 5.95B 890M Mar/2026
Fujikura JPY 295.94B 4.85B Dec/2025
Furukawa JPY 52.34B 3.3B Dec/2025
General Electric Aerospace USD 11.6B 270M Mar/2026
Hitachi JPY 3.08T 370B Mar/2026
Illumina USD 1.16B 80M Dec/2025
IQVIA Holdings USD 4.36B 260M Dec/2025
Mettler Toledo International USD 1.13B 100M Dec/2025
Mitsubishi Electric JPY 1.42T 0 Dec/2025
Mitsubishi Heavy Industries JPY 1.21T 289.93B Dec/2025
Myriad Genetics USD 209.8M 4.1M Dec/2025
Nikon Corporation JPY 170.99B 16.2B Dec/2025
Olympus JPY 261.05B 13.21B Dec/2025
Repligen USD 197.91M 8.91M Dec/2025
Revvity USD 772.06M 73.06M Dec/2025
Smiths GBP 1.44B 133M Jan/2026
Thermo Fisher Scientific USD 11.01B 1.2B Mar/2026
Waters USD 932M 132M Dec/2025